Streetwise Reports' Article Archives — Current Month (8)

Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine (07/09/2020)

Altimmune shares reached a new 52-week high after the company reported it is collaborating with DynPort Vaccine on U.S. government funding efforts for AdCOVIDô, its COVID-19 vaccine candidate.

more>

Biotech with Phase 3 Rheumatoid Arthritis and Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts' (07/08/2020)

An update on Can-Fite BioPharma's multiple drug treatment trials is provided in a Dawson James report.

more>

Preclinical COVID-19 Vaccine Data 'Encouraging' (07/08/2020)

Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report.

more>

Biopharma Starts Enrollment Screening for Phase 2 Pulmonary Fibrosis, Cough Trial (07/08/2020)

In the study, Algernon Pharmaceuticals will test an existing drug that is being repurposed for these indications.

more>

Analyst: G1 Minimizes the Carnage of Chemotherapy (07/01/2020)

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA.

more>

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug (07/01/2020)

Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report.

more>

Life Sciences Firm Submits IND Application to FDA for Phase 3 COVID-19 Study (07/01/2020)

Revive Therapeutics submitted an Investigational New Drug Application to the FDA for a Phase 3 confirmatory study of Bucillamine for treatment in SARS-CoV-2.

more>

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study (07/01/2020)

Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients.

more>

More Archives

2020Jun May Apr Mar Feb Jan

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes